362 related articles for article (PubMed ID: 19650157)
1. Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice.
Osterreicher CH; Taura K; De Minicis S; Seki E; Penz-Osterreicher M; Kodama Y; Kluwe J; Schuster M; Oudit GY; Penninger JM; Brenner DA
Hepatology; 2009 Sep; 50(3):929-38. PubMed ID: 19650157
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-(1-7), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat.
Lubel JS; Herath CB; Tchongue J; Grace J; Jia Z; Spencer K; Casley D; Crowley P; Sievert W; Burrell LM; Angus PW
Clin Sci (Lond); 2009 Sep; 117(11):375-86. PubMed ID: 19371232
[TBL] [Abstract][Full Text] [Related]
3. Cardiac protective effects of irbesartan via the PPAR-gamma signaling pathway in angiotensin-converting enzyme 2-deficient mice.
Zhang ZZ; Shang QH; Jin HY; Song B; Oudit GY; Lu L; Zhou T; Xu YL; Gao PJ; Zhu DL; Penninger JM; Zhong JC
J Transl Med; 2013 Sep; 11():229. PubMed ID: 24067190
[TBL] [Abstract][Full Text] [Related]
4. Prevention of angiotensin II-mediated renal oxidative stress, inflammation, and fibrosis by angiotensin-converting enzyme 2.
Zhong J; Guo D; Chen CB; Wang W; Schuster M; Loibner H; Penninger JM; Scholey JW; Kassiri Z; Oudit GY
Hypertension; 2011 Feb; 57(2):314-22. PubMed ID: 21189404
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of angiotensin-converting enzyme (ACE) 2 in hepatic fibrosis by ACE inhibitors.
Huang ML; Li X; Meng Y; Xiao B; Ma Q; Ying SS; Wu PS; Zhang ZS
Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):e1-6. PubMed ID: 19793108
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of components of the renin-angiotensin system in liver fibrosis in the rat induced by CCL₄.
Zhang W; Miao J; Li P; Wang Y; Zhang Y
Res Vet Sci; 2013 Aug; 95(1):54-8. PubMed ID: 23433841
[TBL] [Abstract][Full Text] [Related]
7. ACE2 Therapy Using Adeno-associated Viral Vector Inhibits Liver Fibrosis in Mice.
Mak KY; Chin R; Cunningham SC; Habib MR; Torresi J; Sharland AF; Alexander IE; Angus PW; Herath CB
Mol Ther; 2015 Sep; 23(9):1434-43. PubMed ID: 25997428
[TBL] [Abstract][Full Text] [Related]
8. Deletion of angiotensin-converting enzyme 2 exacerbates renal inflammation and injury in apolipoprotein E-deficient mice through modulation of the nephrin and TNF-alpha-TNFRSF1A signaling.
Jin HY; Chen LJ; Zhang ZZ; Xu YL; Song B; Xu R; Oudit GY; Gao PJ; Zhu DL; Zhong JC
J Transl Med; 2015 Aug; 13():255. PubMed ID: 26245758
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: a positive feedback mechanism in the RAS.
Patel VB; Clarke N; Wang Z; Fan D; Parajuli N; Basu R; Putko B; Kassiri Z; Turner AJ; Oudit GY
J Mol Cell Cardiol; 2014 Jan; 66():167-76. PubMed ID: 24332999
[TBL] [Abstract][Full Text] [Related]
10. Loss of angiotensin converting enzyme II (ACE2) accelerates the development of liver injury induced by thioacetamide.
Wu HT; Chuang YW; Huang CP; Chang MH
Exp Anim; 2018 Feb; 67(1):41-49. PubMed ID: 28845018
[TBL] [Abstract][Full Text] [Related]
11. Swertiamarin Attenuates Experimental Rat Hepatic Fibrosis by Suppressing Angiotensin II-Angiotensin Type 1 Receptor-Extracellular Signal-Regulated Kinase Signaling.
Li S; Wang Q; Tao Y; Liu C
J Pharmacol Exp Ther; 2016 Nov; 359(2):247-255. PubMed ID: 27543328
[TBL] [Abstract][Full Text] [Related]
12. Portal pressure responses and angiotensin peptide production in rat liver are determined by relative activity of ACE and ACE2.
Herath CB; Lubel JS; Jia Z; Velkoska E; Casley D; Brown L; Tikellis C; Burrell LM; Angus PW
Am J Physiol Gastrointest Liver Physiol; 2009 Jul; 297(1):G98-G106. PubMed ID: 19389807
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin-converting enzyme 2 is a critical determinant of angiotensin II-induced loss of vascular smooth muscle cells and adverse vascular remodeling.
Patel VB; Zhong JC; Fan D; Basu R; Morton JS; Parajuli N; McMurtry MS; Davidge ST; Kassiri Z; Oudit GY
Hypertension; 2014 Jul; 64(1):157-64. PubMed ID: 24799609
[TBL] [Abstract][Full Text] [Related]
14. Activation of the MAS receptor by angiotensin-(1-7) in the renin-angiotensin system mediates mesenteric vasodilatation in cirrhosis.
Grace JA; Klein S; Herath CB; Granzow M; Schierwagen R; Masing N; Walther T; Sauerbruch T; Burrell LM; Angus PW; Trebicka J
Gastroenterology; 2013 Oct; 145(4):874-884.e5. PubMed ID: 23796456
[TBL] [Abstract][Full Text] [Related]
15. Possible role of angiotensin-converting enzyme 2 and activation of angiotensin II type 2 receptor by angiotensin-(1-7) in improvement of vascular remodeling by angiotensin II type 1 receptor blockade.
Ohshima K; Mogi M; Nakaoka H; Iwanami J; Min LJ; Kanno H; Tsukuda K; Chisaka T; Bai HY; Wang XL; Ogimoto A; Higaki J; Horiuchi M
Hypertension; 2014 Mar; 63(3):e53-9. PubMed ID: 24379178
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme 2 improves liver fibrosis in mice by regulating autophagy of hepatic stellate cells.
Wu Y; Yin AH; Sun JT; Xu WH; Zhang CQ
World J Gastroenterol; 2023 Sep; 29(33):4975-4990. PubMed ID: 37732000
[TBL] [Abstract][Full Text] [Related]
17. Alamandine attenuates hepatic fibrosis by regulating autophagy induced by NOX4-dependent ROS.
Huang Y; Li Y; Lou A; Wang GZ; Hu Y; Zhang Y; Huang W; Wang J; Li Y; Zhu X; Chen T; Lin J; Meng Y; Li X
Clin Sci (Lond); 2020 Apr; 134(7):853-869. PubMed ID: 32227122
[TBL] [Abstract][Full Text] [Related]
18. The role of renin-angiotensin system modulation on treatment and prevention of liver diseases.
Moreira de Macêdo S; Guimarães TA; Feltenberger JD; Sousa Santos SH
Peptides; 2014 Dec; 62():189-96. PubMed ID: 25453980
[TBL] [Abstract][Full Text] [Related]
19. Identification of prolyl carboxypeptidase as an alternative enzyme for processing of renal angiotensin II using mass spectrometry.
Grobe N; Weir NM; Leiva O; Ong FS; Bernstein KE; Schmaier AH; Morris M; Elased KM
Am J Physiol Cell Physiol; 2013 May; 304(10):C945-53. PubMed ID: 23392115
[TBL] [Abstract][Full Text] [Related]
20. Antagonism of angiotensin 1-7 prevents the therapeutic effects of recombinant human ACE2.
Patel VB; Takawale A; Ramprasath T; Das SK; Basu R; Grant MB; Hall DA; Kassiri Z; Oudit GY
J Mol Med (Berl); 2015 Sep; 93(9):1003-13. PubMed ID: 25874965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
